COYA Treg-directed combo therapies show early promise in ALS, FTD
TradingView News reports COYA’s Treg-directed combination therapies show promising early clinical signals in ALS and FTD, with key data expected in 2027.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.